Type II Acute Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation Treated with High Flow Nasal Cannula (HFNC): Case Report
Case Report
DOI:
https://doi.org/10.55175/cdk.v53i01.1805Keywords:
Acute respiratory failure, high flow nasal cannula, case report, smoking, acute exacerbation of COPD, dyspneaAbstract
Introduction: Acute respiratory failure is a condition seen in respiratory system failure to supply gas exchange, oxygenation, and elimination of carbon dioxide (CO2) processes that occurs in minutes or hours. Case: A 57-year-old male came to the emergency room with complaints of shortness of breath since 5 days ago, worsened during light activities. The patient also complained of worsening cough since 5 days ago, accompanied by thick yellowish-white phlegm. History of smoking 12 sticks/day since the age of 20 years and quit 5 years ago. Diagnosis was acute respiratory failure type II and the cause was chronic obstructive pulmonary disease (COPD) acute exacerbation. The management is high flow nasal cannula (HFNC) with FiO2 80%, because HFNC has an additional heating and humidification system that makes it more comfortable. Discussion: Alveolar hypoventilation and increased minute ventilation in COPD patients may carry a type II acute respiratory failure risk. Conclusion: Type II acute respiratory failure commonly occurs in patients with chronic respiratory diseases such as COPD. High flow nasal cannula (HFNC) oxygen therapy may be the best option.
Downloads
References
PDPI (Perhimpunan Dokter Paru Indonesia). Panduan umum praktik klinis penyakit paru dan pernapasan. Jakarta: Indonesia; 2021.
Grippi MA, Elias JA, Fisherman JA, Kotloff RM, Pack Al, Senior RM. Fishman’s pulmonary disease and disorders. 2-volume set. 6th Ed. USA:McGraw-Hill Education; 2022. p. 2773.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. 2023. Available from: https://goldcopd.org/wp-content/uploads/2023/03/GOLD-2023-ver-1.3-17Feb2023_WMV.pdf.
Elhidsi M. Modalitas terapi oksigen pada gagal napas akut [Internet]. Medical Stadium Generale, PDPI; 2022. Available from: https://www.youtube.com/watch?v=6NGiJJSBvM8.
Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Setyohadi B, Syam AF. Buku ajar ilmu penyakit dalam. 6th Ed. Jilid 1. Jakarta Pusat: Interna Publishing; 2014.
Sherwood L. Introduction to human physiology. 8th Ed. Brook/Cole: Cengage Learning; 2013.
Soebekti W, Zulfikar T, Priyanto H. Non-invasive respiratory support strategy in adults with acute respiratory failure. J Respirol Indon.2024;44(2):179−86. https://doi.org/10.36497/jri.v44i2.650.
Simonds AK. ERS practical handbook of noninvasive ventilation. Vol 11. Breathe. Sheffield: European Respiratory Society; 2015.
Bourke SC, Piraino T, Pisani L, Brochard L, Elliott MW. Beyond the guidelines for non-invasive ventilation in acute respiratory failure: implication for practice. Lancet Respir Med. 2018;6:935−47. doi: 10.1016/S2213-2600(18)30388-6.
Ashraf-Kashani N, Kumar R. High flow nasal oxygen therapy. BJA Edu. 2017;17(2):63−7. doi: 10.1093/bjaed/mkw041.
Rochwerg B, Brochard L, Elliot MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):4−8. https://doi.org/10.1183/13993003.02426-2016.
Wendel-Garcia PD, Mas A, Gonzalez-Isern C, Ferrer R, Manez R, Masclans JR, et al. Non-invasive oxygenation support in acutely hypoxemic COVID-19 patients admitted to the ICU: a multicenter observational retrospective study. Crit Care. 2022;26(1):37. https://doi.org/10.1186/s13054-022-03905-5.
Patel M, Gangemi A, Marron R, Chowdhury J, Yousef I, Zheng M, et al. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure. BMJ Open Resp Res. 2020;7(1):e000650. https://doi.org/10.1136/bmjresp-2020-000650.
Calligaro GL, Lalla U, Audley G, Ginaa P, Millerb MG, Mendelson M, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: a multi-centre prospective observational study. EClinicalMed. 2020;28:3−6. https://doi.org/10.1016/j.eclinm.2020.100570.
Helviz Y, Einav S. A systematic review of the high-flow nasal cannula for adult patients. Crit Care. 2018 Mar 20;22(1):71. doi: 10.1186/s13054-018-1990-4.
Soebekti W, Taufik FF, Elhidsi M. Clinical characteristic and outcome of covid-19 patient using high flow nasal cannula in Persahabatan Hospital, Jakarta. J Respirol Indon. 2022;42:3. https://doi.org/10.36497/jri.v42i3.367.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Abdi Malik Rahardjo, Mokhammad Mukhlis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
